Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT00575159. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2
ClinicalTrials.gov study NCT04729972. IPD Sharing: NO. Countries: 2. Publications: 1.
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01627340. IPD Sharing: YES. Countries: 4. Publications: 1.
Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment
ClinicalTrials.gov study NCT01164501. IPD Sharing: Not stated. Countries: 15. Publications: 4.
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
ClinicalTrials.gov study NCT02725593. IPD Sharing: YES. Countries: 7. Publications: 1.
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01475461. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
ClinicalTrials.gov study NCT01388361. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02622113. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insu
ClinicalTrials.gov study NCT02585778. IPD Sharing: Not stated. Countries: 10. Publications: 3.
Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy
ClinicalTrials.gov study NCT02421510. IPD Sharing: Not stated. Countries: 17. Publications: 5.
Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01084005. IPD Sharing: Not stated. Countries: 5. Publications: 3.
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
ClinicalTrials.gov study NCT05403502. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity
ClinicalTrials.gov study NCT00985114. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
ClinicalTrials.gov study NCT02545049. IPD Sharing: NO. Countries: 48. Publications: 20.
A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Contr
ClinicalTrials.gov study NCT01809327. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design
ClinicalTrials.gov study NCT00798161. IPD Sharing: Not stated. Countries: 14. Publications: 1.
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT00474630. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
ClinicalTrials.gov study NCT02500706. IPD Sharing: YES. Countries: 13. Publications: 2.
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
ClinicalTrials.gov study NCT01154101. IPD Sharing: YES. Countries: 1. Publications: 1.
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02773368. IPD Sharing: Not stated. Countries: 11. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.